Rizwan Ullah: Managing Severe Tirofiban-Induced Thrombocytopenia
Rizwan Ullah, Cardiologist at Ministry of Health and Prevention – UAE, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Pakistan Heart Journal, adding:
“Excited to share another academic milestone!
I’m delighted to announce that our case report has been published in the Pakistan Heart Journal.
Tirofiban-Induced Severe Thrombocytopenia Following Primary Percutaneous Coronary Intervention: A Case Report
As interventional cardiologists, we often focus on preventing thrombotic complications during primary PCI.
However, this case is a powerful reminder that life-threatening complications can arise from the very therapies we rely on.
In our patient with anterior STEMI, the platelet count plummeted from 211 × 10⁹/L to just 6 × 10⁹/L within 9 hours of tirofiban administration.
Rapid recognition, prompt discontinuation of the drug, and treatment with IVIG resulted in complete recovery without major bleeding or thrombotic events.
Key clinical takeaways:
- Always monitor platelet counts early after initiating GP IIb/IIIa inhibitors.
- Consider tirofiban-induced immune thrombocytopenia when platelet counts fall abruptly.
- Early diagnosis and multidisciplinary management can be lifesaving.
- IVIG may play an important role in severe immune-mediated cases.
This publication reflects the dedication of an outstanding multidisciplinary team.
I’m grateful to my co-authors and colleagues for their expertise, collaboration, and commitment to advancing patient care.
Every published case has the potential to help another clinician make the right decision at the right time—and ultimately save a life. That’s the true value of sharing clinical experience.
Thank you to the editorial team and reviewers of the Pakistan Heart Journal for this opportunity.
I’d be happy to hear your thoughts or experiences with GP IIb/IIIa inhibitor-induced thrombocytopenia in your practice.”
Title: Tirofiban-Induced Severe Thrombocytopenia Following Primary Percutaneous Coronary Intervention: A Case Report
Authors: Ashraf Ismail, Rizwan Ullah Sher, Arif Al, Nooryani, Farah Alaila, Bassam Al-Baba, Nagwa Abdelrahman
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 09:18Sarra Hmidi: Tunisia Highlights Thrombosis Prevention on World Thrombosis Day
-
Oct 17, 2026, 09:05Addressing the Hidden Burden of Bleeding Disorders in Women – Hemophilia Society Mumbai Chapter
-
Oct 17, 2026, 08:49Maria Magnusson: Karolinska Experts Explore Gene Therapy in Sickle Cell Disease and Hemophilia
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK